Company Overview of The Blackstone Group, Private Equity Group
The Blackstone Group, Private Equity Group is an investment firm specializing in direct and fund of funds investments. For direct investments in the firm seeks to invest in middle market, leveraged buyouts, distressed investments, structured equity, rescue financings, turnarounds, minority investments, large private transactions, large public-to-privates corporate partnerships, platform buildups, industry consolidations, start-ups in established industries, small and medium size buyouts, recapitalizations, PIPES, mature, late venture, growth capital and direct secondaries investments. The firm also prefers to invest in out-of-favor, under-appreciated industries. It seeks to invest in a broad...
345 Park Avenue
New York, NY 10154
Founded in 1987
Key Executives for The Blackstone Group, Private Equity Group
Chief Executive Officer of Equity Healthcare
Co-Founder and Chief Executive Officer
Senior Managing Director and Chairman
Senior Managing Director and Global Head of Energy and Natural Resources
Compensation as of Fiscal Year 2014.
The Blackstone Group, Private Equity Group Key Developments
Weather Channel Owners Reportedly Eye Sale
Sep 13 14
The Blackstone Group, Private Equity Group, NBCUniversal Media, LLC and Bain Capital Private Equity are looking for possible strategic options including a possible sale of The Weather Channel, LLC, Bloomberg reported citing people familiar with the matter. It is believed that Weather Channel hasn't begun a formal process or hired a bank. The Blackstone Group, Private Equity Group, NBCUniversal Media, LLC and Bain Capital Private Equity are in talks with JPMorgan Chase & Co. and Goldman Sachs Group Inc.
Private Equity Groups Reportedly Plan Merger Of GlaxoSmithKline And Sanofi Brands
Aug 3 14
Kohlberg Kravis Roberts & Co. (NYSE:KKR) and Warburg Pincus LLC are among the private equity groups that are exploring a $10 billion plan to acquire hundreds of older drug brands from GlaxoSmithKline plc (LSE:GSK) and Sanofi (ENXTPA:SAN) and merge them, several people familiar with the matter said. GSK had received “very significant” indicative bids from private equity companies and midsized drug makers in a portfolio of mature products with annual sales of about £1 billion. Sanofi is alos looking at divesting about 200 older drugs with annual revenues of at least €2.1 billion. Other private equity groups to have expressed interest in one or both of the portfolios include The Blackstone Group, Private Equity Group, Advent International Corporation, Apollo Global Management, LLC (NYSE:APO) and Bain Capital Ventures, said people close to the matter. The people added that the concept of rolling the two sets of assets together is still at an early stage as Sanofi is yet to make a firm decision on what to do with its portfolio. However, work is being done by potential bidders on a potential combination, those people stated. Mylan, Inc. (NasdaqGS:MYL) and Lupin Limited (BSE:500257) are among potential trade buyers to have been linked with one or both of the GSK and Sanofi businesses. GSK and Sanofi are being advised by Lazard and Evercore respectively.
IDFC Reportedly Plans To Divest IT Parks
Jul 1 14
IDFC Limited (BSE:532659) intends to divest two IT parks for a about INR 1.1 billion. Sources indicated that bidder looking at acquiring the properties are GIC Pte. Ltd., RMZ Corp. Holdings Private Limited, Ascendas Pte, Ltd. along with The Blackstone Group, Private Equity Group the front-runner. IDFC has deferred plans to form a rental yield fund due to subdued market conditions. This perhaps is one of the reasons for divestiture of the IT assets by IDFC, sources added.
Similar Private Companies By Industry
Recent Private Companies Transactions